The Eu­ro­pean Om­buds­man, an in­de­pen­dent in­ves­ti­ga­to­ry body in the EU, called out the EU Com­mis­sion for fail­ing to search for text mes­sages be­tween Com­mis­sion pres­i­dent … ...

The fed­er­al gov­ern­ment has on­ly sent four ship­ments of Mer­ck’s Covid-19 an­tivi­ral mol­nupi­ravir (about 400,000 cours­es in each ship­ment) na­tion­wide, and al­ready HHS is re­port­ing … ...

As the saga over how to pay for Aduhelm plays out, bio­phar­ma com­pa­nies are now look­ing close­ly at how Bio­gen was able to keep such … ...

Con­firmed mon­key­pox cas­es in the US have now sur­passed 300, and as a re­sult, the De­part­ment of Health and Hu­man Ser­vices is mak­ing hun­dreds of … ...

Af­ter its Covid-19 vac­cine can­di­date pe­tered out, Cure­Vac ear­li­er this month filed suit against BioN­Tech in Ger­man court, stat­ing that Cure­Vac should be com­pen­sat­ed … ...

Be­low are no­table up­dates from the Amer­i­can Acad­e­my of Der­ma­tol­ogy’s an­nu­al meet­ing over the week­end: ...

Melanoma was the first can­cer type for which Bris­tol My­ers Squibb’s Op­di­vo scored an FDA ap­proval. And the phar­ma gi­ant is still try­ing to reach … ...

Alex Gorsky, the CEO whose nine-year tenure at J&J was marred by law­suits over the com­pa­ny’s talc ba­by pow­der and opi­oids, will ...

A biotech with an ap­proved non-hor­mon­al birth con­trol gel had hoped it would be at the FDA’s doorsteps in ear­ly 2023 to re­quest a la­bel … ...

As Eli Lil­ly launch­es its new­ly ap­proved weight loss med Zep­bound to much fan­fare, No­vo Nordisk is toss­ing a next-gen can­di­date in the ring. … ...

SAB Bio­ther­a­peu­tics said Thurs­day the US fed­er­al gov­ern­ment is pro­vid­ing it with an ad­di­tion­al $60.5 mil­lion, and more than $200 mil­lion in to­tal, to ad­vance … ...

Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.